[DOI] [PMC free article] [PubMed] [Google Scholar] 63.Kristensen SL, Rorth R, Jhund PS, et al
Across this population, GLP-1 treatment was found to reduce the risk of blood clots by 17%, of pulmonary embolism by 31%, and of death by 44%
Pep is the ideal companion for anyone using a GLP-1 receptor agonist, including: Ozempic (semaglutide) Wegovy (semaglutide for weight loss), including the daily Wegovy pill Mounjaro and Zepbound (tirzepatide) Rybelsus and other oral GLP-1 medications Compounded or generic GLP-1 medications Whether you inject weekly or take a daily pill, you can start logging in minutes and download Pep free to keep your whole routine in one app
In partnership with Pendulum
But many of the biggest launches werent new SKUs
In orforglipron's study, up to 10% of patients stopped treatment, compared with 3% on placebo